Fabior Side Effects

Generic Name: tazarotene topical

Note: This page contains information about the side effects of tazarotene topical. Some of the dosage forms included on this document may not apply to the brand name Fabior.

Not all side effects for Fabior may be reported. You should always consult a doctor or healthcare professional for medical advice. Side effects can be reported to the FDA here.

For the Consumer

Applies to tazarotene topical: topical cream, topical foam, topical gel/jelly

In addition to its needed effects, some unwanted effects may be caused by tazarotene topical (the active ingredient contained in Fabior). In the event that any of these side effects do occur, they may require medical attention.

You should check with your doctor immediately if any of these side effects occur when taking tazarotene topical:

More common
  • Burning or stinging of the skin (severe)
  • changes in color of the treated skin
  • deep grooves or lines in the skin
  • dryness, itching, peeling, or redness of the skin (severe)
  • pain or swelling of the treated skin
  • skin rash (in patients with psoriasis only)

Some of the side effects that can occur with tazarotene topical may not need medical attention. As your body adjusts to the medicine during treatment these side effects may go away. Your health care professional may also be able to tell you about ways to reduce or prevent some of these side effects. If any of the following side effects continue, are bothersome or if you have any questions about them, check with your health care professional:

More common
  • Burning or stinging after application
  • dryness, itching, peeling, or redness of the skin (mild)

For Healthcare Professionals

Applies to tazarotene topical: topical cream, topical foam, topical gel

Dermatologic

Dermatologic side effects associated with Avage(R) topical cream have included desquamation (40%), erythema (34%), burning sensation (26%), dry skin (16%), skin irritation (10%), pruritus (10%), irritant contact dermatitis (8%), stinging (3%), acne (3%), rash (3%), and cheilitis (1%). Pruritus, erythema, and burning have been reported (in descending order) with Tazorac(R) topical cream in 10% to 23% of psoriasis patients. Desquamation, dry skin, erythema, and burning sensation have been reported (in descending order) with Tazorac(R) topical cream in 10% to 30% of acne patients. Irritation, desquamation, stinging, contact dermatitis, dermatitis, eczema, worsening of psoriasis, skin pain, rash, dry skin, and skin inflammation have been reported (in descending order) with Tazorac(R) topical cream in greater than 1% to less than 10% of psoriasis patients. Pruritus, irritation, face pain, and stinging have been reported with Tazorac(R) topical cream in 1% to 5% of acne patients. Dermatitis (less than 1%), impetigo (less than 1%), pruritus (less than 1%), local skin reactions, dryness, erythema, peeling, burning/stinging, and itching have been reported with tazarotene topical (the active ingredient contained in Fabior) foam. Pruritus, burning/stinging, erythema, worsening of psoriasis, irritation, and skin pain have been reported (in descending order) with tazarotene topical gel in 10% to 30% of psoriasis patients. Desquamation, burning/stinging, dry skin, erythema, and pruritus have been reported (in descending order) with tazarotene topical gel in 10% to 30% of acne patients. Rash, desquamation, irritant contact dermatitis, skin inflammation, fissuring, bleeding, and dry skin have been reported with tazarotene topical gel in 1% to 10% of psoriasis patients. Irritation, skin pain, fissuring, and skin discoloration have been reported with tazarotene topical gel in 1% to 10% of acne patients. Psoriasis worsening and sun-induced erythema have also been reported with tazarotene topical gel in psoriasis patients. Blister, rash, skin discoloration (including skin hyperpigmentation or skin hypopigmentation), and pain have been reported during postmarketing experience with tazarotene topical gel.

Local

Local side effects associated with tazarotene topical (the active ingredient contained in Fabior) foam have included application site irritation (14%), application site dryness (7%), application site erythema (6%), application site exfoliation (6%), application site pain (1%), application site photosensitivity (including sunburn; 1%), application site pruritus (1%), application site dermatitis (1%), and application site reactions (including discoloration, discomfort, edema, rash, and swelling; less than 1%). Localized edema has been reported with tazarotene topical gel in 1% to 10% of acne patients.

Metabolic

Metabolic side effects associated with Tazorac(R) topical cream have included hypertriglyceridemia (greater than 1% to less than 10%).

Other

Other side effects associated with Tazorac(R) topical cream have included peripheral edema (greater than 1% to less than 10%).

Ocular

Ocular side effects associated with Avage(R) topical cream have included edema, irritation, and inflammation directly related to the eye or eyelid.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate safety, effectiveness, or appropriateness for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of materials provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the substances you are taking, check with your doctor, nurse, or pharmacist.

Hide
(web2)